Synaptic vesicle proteins in cerebrospinal fluid as potential biochemical markers for synaptic pathology in Alzheimer's disease

被引：0
|
作者：
Blennow, K [1 ]
Davidsson, P [1 ]
Bergquist, J [1 ]
Ekman, R [1 ]
机构：
[1] GOTHENBURG UNIV,MOLNDAL HOSP,INST CLIN NEUROSCI,DEPT NEUROCHEM,S-41380 MOLNDAL,SWEDEN
来源：
JOURNAL OF NEUROCHEMISTRY | 1996年 / 66卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [21] Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease
    Shimohama, S
    Kamiya, S
    Taniguchi, T
    Akagawa, K
    Kimura, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 239 - 242
  • [22] Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease
    Yao, PJ
    TRENDS IN NEUROSCIENCES, 2004, 27 (01) : 24 - 29
  • [23] The role of synaptic proteins in Alzheimer's disease
    Masliah, E
    ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 68 - 75
  • [24] Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
    Julie Goossens
    Alba Cervantes González
    Nele Dewit
    Laia Lidón
    Juan Fortea
    Daniel Alcolea
    Alberto Lleó
    Olivia Belbin
    Eugeen Vanmechelen
    Alzheimer's Research & Therapy, 15
  • [25] Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum
    Goossens, Julie
    Cervantes Gonzalez, Alba
    Dewit, Nele
    Lidon, Laia
    Fortea, Juan
    Alcolea, Daniel
    Lleo, Alberto
    Belbin, Olivia
    Vanmechelen, Eugeen
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [26] MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
    Kiko, Takehiro
    Nakagawa, Kiyotaka
    Tsuduki, Tsuyoshi
    Furukawa, Katsutoshi
    Arai, Hiroyuki
    Miyazawa, Teruo
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (02) : 253 - 259
  • [27] Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease
    Choe, LH
    Dutt, MJ
    Relkin, N
    Lee, KH
    ELECTROPHORESIS, 2002, 23 (14) : 2247 - 2251
  • [28] Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
    Kester, Maartje I.
    Teunissen, Charlotte E.
    Crimmins, Daniel L.
    Herries, Elizabeth M.
    Ladenson, Jack. H.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Morris, John C.
    Holtzman, David M.
    Fagan, Anne M.
    JAMA NEUROLOGY, 2015, 72 (11) : 1275 - 1280
  • [29] Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
    Reddy, PH
    Mani, G
    Park, BS
    Jacques, J
    Murdoch, G
    Whetsell, W
    Kaye, J
    Manczak, M
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (02) : 103 - 117
  • [30] Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease
    Wang, Jie
    Huang, Qi
    Chen, Xing
    You, Zhiwen
    He, Kun
    Guo, Qihao
    Huang, Yiyun
    Yang, Yang
    Lin, Zengping
    Guo, Tengfei
    Zhao, Jun
    Guan, Yihui
    Li, Binyin
    Xie, Fang
    MOLECULAR PSYCHIATRY, 2024, 29 (9) : 2799 - 2809
12345